Alpha-Fetoprotein (AFP) Tumor Marker Test: Purpose, Process, and Results

A comprehensive guide to the AFP tumor marker test, its role in cancer diagnosis and monitoring, and what your results may mean.

By Medha deb
Created on

Alpha-Fetoprotein (AFP) Tumor Marker Test

Alpha-fetoprotein (AFP) is a key protein produced mainly by the developing fetus and, in adults, by certain tumor cells. The AFP tumor marker test is a laboratory blood test used to detect and monitor specific cancers, particularly of the liver, testicles, and ovaries, as well as to help manage other liver conditions.

What Is Alpha-Fetoprotein (AFP)?

Alpha-fetoprotein (AFP) is a protein made by the fetus’s yolk sac, liver, and digestive tract during early development. After birth, the body typically produces only minimal amounts of AFP, so higher levels in children and adults may signal certain diseases or health conditions.

  • AFP in pregnancy: Used to assess risk of birth defects and genetic disorders in the fetus.
  • AFP in non-pregnant adults: Primarily a tumor marker for cancers and for evaluating liver health.

Why Is the AFP Tumor Marker Test Ordered?

The test has two major roles depending on the patient:

  • For non-pregnant individuals – Used to detect and monitor certain cancers and liver diseases.
  • For those with chronic liver disease – Helps assess risk and monitor development of liver cancer.

Cancers and Conditions Associated with Elevated AFP

An elevated AFP level may signal a range of cancers and other noncancerous conditions:

  • Liver cancer (hepatocellular carcinoma)
  • Nonseminomatous testicular cancer
  • Ovarian germ cell tumors
  • Bile duct, stomach, colon, pancreas, or lung cancers (less common)
  • Lymphoma and childhood central nervous system germ cell tumors
  • Other non-cancerous conditions such as hepatitis and cirrhosis
  • Rare genetic conditions like ataxia-telangiectasia

For pregnant women, the test is generally used for different reasons related to fetal health and is interpreted differently.

When and Why Is the Test Used?

Your healthcare provider may order the AFP tumor marker test to:

  • Help diagnose or monitor therapy for liver, testicular, or ovarian cancer
  • Track treatment response or detect cancer recurrence following therapy
  • Support diagnosis and ongoing management of chronic liver diseases (such as hepatitis or cirrhosis)
  • Screen for specific fetal abnormalities during pregnancy (when performed as a maternal AFP test)

How Is the AFP Tumor Marker Test Performed?

The AFP test is a simple blood test usually performed in a clinical laboratory setting. The collection process involves drawing a small amount of blood from a vein in your arm:

  • Preparation: No special preparations are necessary. Fasting is not typically required.
  • Procedure: A healthcare professional will use a sterile needle to withdraw blood, which is then analyzed in a lab.
  • For children: Blood may be collected from a finger or heel stick if needed.

Risks Associated with the Test

  • Mild discomfort or bruising at the site of needle entry
  • Very rare risk of infection or dizziness
  • No significant long-term risks

Reference Ranges and Interpretation of AFP Levels

AFP concentrations are measured in nanograms per milliliter (ng/mL). The normal ranges can vary according to age, sex, and laboratory methodology. In healthy children and adults not pregnant:

Age GroupNormal AFP Levels (ng/mL)
Newborns (<1 Month)0.5 – 16,387 (Male), 0.5 – 18,964 (Female)
1-11 Months0.5 – 28.3 (Male), 0.5 – 77.0 (Female)
1-3 Years0.5 – 7.9 (Male), 0.5 – 11.1 (Female)
>3 Years (Children and Adults)<6.1 (Both Male and Female)

For pregnant people, levels are interpreted based on gestational age and the context of prenatal screening.

Interpreting Elevated or Abnormal AFP Results

High or abnormal AFP levels require careful interpretation and usually further investigation:

  • Significantly elevated AFP may suggest liver cancer, germ cell tumors, or a noncancerous liver condition.
  • Slightly elevated AFP can occur in some benign liver disorders, and not all individuals with cancer have high AFP levels.
  • For monitoring treatment: A decline in AFP after therapy may indicate successful treatment, while rising levels can signal persistence or recurrence of disease.

AFP results are never used alone; doctors consider your medical history, other test results, and physical examination.

What Happens If a Change or Abnormality Is Detected?

If your AFP levels are above or below the expected range, your healthcare team will:

  • Discuss possible causes based on your personal and family medical history
  • Recommend additional diagnostic tests (such as imaging or biopsy) or repeat AFP tests to monitor trends
  • Provide guidance about next steps, which may include specialist referral, further monitoring, or treatment as appropriate

Factors That Can Affect AFP Levels

Several factors can influence or temporarily raise AFP, including:

  • Recent liver injury or infection
  • Certain genetic conditions
  • Pregnancy (normal for AFP to be high)
  • Other underlying noncancerous or cancerous medical conditions

Because of these factors, doctors never use AFP testing as the sole screening method for cancer in the general population.

Limitations of the AFP Tumor Marker Test

  • It is not recommended for cancer screening in people without symptoms or risk factors.
  • False positives may occur in liver diseases like hepatitis or cirrhosis.
  • Certain small tumors or early cancers may not elevate AFP levels at all.
  • A normal AFP result does not rule out cancer if clinical suspicion is high.

Other Uses of the AFP Test

Besides cancer diagnosis and monitoring, the AFP test can also:

  • Be combined with other blood tests to form part of the triple or quad screen in prenatal care for birth defect risk assessment
  • Monitor chronic liver disease progression or response to medical interventions

Related Tests

  • Amniocentesis: Used in pregnancy to analyze levels of AFP in amniotic fluid when birth defects are suspected.
  • Other Tumor Markers: Additional blood tests, such as beta-hCG, CA-125, or CEA, may be requested alongside AFP for comprehensive cancer evaluation.

Frequently Asked Questions (FAQs)

Who should have an AFP tumor marker test?

The test is mainly ordered for individuals with known or suspected liver, testicular, or ovarian cancer, or for those being monitored for recurrence or progression of these cancers. It may also be recommended for patients with chronic liver disease at high risk for liver cancer.

Can an AFP test diagnose cancer by itself?

No. High AFP levels can indicate cancer or other liver conditions but must be interpreted with other clinical evidence and diagnostic tests. A definitive diagnosis of cancer typically requires imaging and sometimes biopsy.

Should everyone have an AFP test to screen for cancer?

No. AFP testing is not recommended as a general screening tool for cancer in the general population. It is most useful in people already diagnosed with certain types of cancers or in those at high risk due to chronic liver disease.

Do abnormal AFP levels always mean cancer is present?

No. Elevated AFP can result from noncancerous conditions, and not every cancer will cause AFP to rise. Additional testing is usually required for an accurate diagnosis.

What does a low or normal AFP level mean?

Most healthy adults have very low to undetectable AFP levels. Low or normal AFP in adults is typically considered normal, but in the context of monitoring certain cancers where AFP was initially high, a decrease may be a sign of treatment response.

How soon are results available?

AFP test results are usually available within a few days. Your healthcare provider will interpret the numbers and discuss what they mean for your health.

Summary Table: Key Information on AFP Tumor Marker Test

AspectDetails
Test typeBlood test (serum/plasma)
PurposeDetect/monitor liver and germ cell cancers; monitor chronic liver disease
Normal adult range<6.1 ng/mL
RisksMinimal (mild bruising, discomfort)
PreparationNo special preparation needed
Other usesPrenatal screening, chronic liver problem monitoring

When to Discuss AFP Testing with Your Provider

  • If you have symptoms suggestive of liver, testicular, or ovarian cancer
  • If you have a chronic liver disease with increased risk of cancer
  • As part of prenatal care (for maternal AFP, not tumor marker test)
  • If you are undergoing or have completed cancer treatment and need monitoring for recurrence

Glossary

  • Tumor marker: A substance found in blood, urine, or tissues that may indicate the presence of certain cancers.
  • Hepatocellular carcinoma: The most common form of primary liver cancer in adults.
  • Germ cell tumors: Tumors that originate from reproductive cells; often found in the ovaries or testicles.
  • Immunoassay: Laboratory technique for measuring substances such as AFP in blood using the immune response.

Further Reading and Resources

  • Talk to your healthcare provider for personalized medical advice.
  • Visit reputable medical websites and cancer organizations for up-to-date information.
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb